Page last updated: 2024-08-24

plerixafor and Combined Immunodeficiency, X-Linked

plerixafor has been researched along with Combined Immunodeficiency, X-Linked in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adair, JE; Burtner, CR; Chan, F; Felsburg, PJ; Hubbard, NW; Humbert, O; Humphrys, D; Kiem, HP; Norgaard, ZK; O'Donnell, P; Rajawat, YS; Rawlings, DJ; Scharenberg, AM; Torgerson, TR; Trobridge, GD	1

Other Studies

1 other study(ies) available for plerixafor and Combined Immunodeficiency, X-Linked

Article	Year
Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy. Blood advances, 2018, 05-08, Volume: 2, Issue:9 Topics: Animals; Benzylamines; CD4-CD8 Ratio; Cyclams; Disease Models, Animal; Dog Diseases; Dogs; Genetic Therapy; Genetic Vectors; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Phosphoglycerate Kinase; Spumavirus; X-Linked Combined Immunodeficiency Diseases	2018

Article

Year

Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy.

Blood advances, 2018, 05-08, Volume: 2, Issue:9

Topics: Animals; Benzylamines; CD4-CD8 Ratio; Cyclams; Disease Models, Animal; Dog Diseases; Dogs; Genetic Therapy; Genetic Vectors; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Phosphoglycerate Kinase; Spumavirus; X-Linked Combined Immunodeficiency Diseases

2018